Shares of iShares Russell Mid-Cap ETF (NYSEARCA:IWR – Get Free Report) saw unusually-strong trading volume on Monday . Approximately 2,976,949 shares were traded during trading, an increase of 136% from the previous session’s volume of 1,263,439 shares.The stock last traded at $88.22 and had previously closed at $87.64.
iShares Russell Mid-Cap ETF Trading Up 0.3 %
The business’s 50 day moving average price is $87.32 and its two-hundred day moving average price is $83.89. The stock has a market cap of $36.32 billion, a P/E ratio of 20.27 and a beta of 1.02.
Institutional Investors Weigh In On iShares Russell Mid-Cap ETF
Large investors have recently modified their holdings of the stock. Paladin Advisory Group LLC bought a new stake in iShares Russell Mid-Cap ETF during the second quarter worth about $27,000. Future Financial Wealth Managment LLC bought a new stake in iShares Russell Mid-Cap ETF during the third quarter worth about $30,000. Sage Mountain Advisors LLC boosted its stake in iShares Russell Mid-Cap ETF by 50.9% during the second quarter. Sage Mountain Advisors LLC now owns 403 shares of the company’s stock worth $33,000 after acquiring an additional 136 shares in the last quarter. Beaird Harris Wealth Management LLC bought a new stake in iShares Russell Mid-Cap ETF during the first quarter worth about $40,000. Finally, Cultivar Capital Inc. bought a new stake in iShares Russell Mid-Cap ETF during the second quarter worth about $41,000.
iShares Russell Mid-Cap ETF Company Profile
iShares Russell Mid-Cap ETF (the Fund), formerly iShares Russell Midcap Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the Russell Midcap Index (the Index). The Index measures the performance of the mid-capitalization sector of the United States equity market.
Further Reading
- Five stocks we like better than iShares Russell Mid-Cap ETF
- What is a buyback in stocks? A comprehensive guide for investors
- Intel: Is Now the Time to Be Brave?Â
- EV Stocks and How to Profit from Them
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for iShares Russell Mid-Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Russell Mid-Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.